Clinical Trials Sponsored by North Texas Infectious Disease Consultants

Total 71 results

Metro Infectious Disease Consultants

Completed

Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19

COVID-19

United States
Denver Infectious Disease Consultants, PLLC
GlaxoSmithKline

Unknown

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects (SHIELD)

HIV Infections

United States
Mazonson & Santas Inc.
Icahn School of Medicine at Mount Sinai; ViiV Healthcare; AIDS Healthcare Foundation and other collaborators

Recruiting

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables (ADHOC-LA)

HIV

United States
National Institute of Allergy and Infectious Diseases...
North American Biologicals Inc

Completed

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

HIV Infections

United States, Puerto Rico
University of North Carolina, Chapel Hill
Centre for Infectious Disease Research in Zambia

Completed

Evaluation of PTB Screening in ANC in Lusaka, Zambia

Pulmonary Tuberculosis

Zambia
Centers for Disease Control and Prevention
Washington University School of Medicine; The Miriam Hospital; Hennepin Healthcare... and other collaborators

Completed

Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)

HIV Infections | Sexually Transmitted Diseases

United States
Institute for Transfusion Medicine of RNM
University Clinic for Infectious Diseases, North Macedonia

Completed

Efficacy and Safety of COVID-19 Convalescent Plasma

COVID-19 | SARS-CoV 2 | Convalescent Plasma

North Macedonia
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

ART Readiness in HIV-infected Pregnant Women

Human Immunodeficiency Virus

Zambia
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV

Tuberculosis

Zambia
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia

HIV Infection

Zambia
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi

HIV Prevention

Malawi
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Supporting Tailored And Responsive PrEP in Rural North Carolina (STARR-NC)

HIV Pre-Exposure Prophylaxis

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women

HIV-1-infection | Antenatal Care

Malawi
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Development of a Mobile-based App to Increase Uptake of Pre-Exposure Prophylaxis (PrEP) by Men Who Have Sex With Men in China

HIV | Pre-exposure Prophylaxis

China
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children

Early Infant HIV Diagnosis

Zambia
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons

HIV-1 Infection

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Normalizing HPV Vaccination in Preteens With a Serious Video Game

Human Papillomavirus

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Mechanisms of Desensitization During Peanut Oral Immunotherapy (PnOIT4)

Food Hypersensitivity

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population

Human Immunodeficiency Virus

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Quantification of Estradiol's Impact on Nucleotides in Cellular Populations of the Lower GI Tract

HIV/AIDS

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda

HIV-1-infection

Uganda
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women (MP3 Pilot)

HIV

Zambia
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Measles

Zambia
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals (Endomac)

Hypersensitivity | Asthma

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1

Pregnancy | HIV | Prevention

Malawi, Zimbabwe
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China

Gonorrhea

China
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3m4 in Persons With HIV-1 Suppressed on ART (CM HIV-Core008)

HIV-1-infection | HIV Vaccine

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Gonorrhea Male

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation

Community-associated Highly-Resistant Enterobacterales (COCARE)

Enterobacteriaceae Infections | Community-Acquired Infections | Healthcare Associated Infection | Carbapenem-Resistant Enterobacteriaceae Infection

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN) (ENLIGHTEN)

Medication Adherence

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults (M&M)

HIV-1 Infection

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Acute Partner and Social Contact Referral: iKnow

Sexually Transmitted Infections | Acute HIV Infection | HIV Seropositive

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)

HIV/AIDS

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (VORVAX)

HIV-1 Infection

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Ulcers of Female Genital Organs

Zambia
Emory University
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

HIV

Malawi
National Institute of Allergy and Infectious Diseases...
The University of Texas Health Science Center, Houston

Completed

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

HIV Infections | Non-Alcoholic Fatty Liver Disease

United States, Brazil
The University of Texas Health Science Center,...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Rapid Characterization of Paucibacillary TB Along Tex/Mex Border

Mycobacterium Tuberculosis

United States, Colombia, Mexico
Michelle Hernandez, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers (Kintox)

Healthy Control Subjects

United States
Kristine Patterson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sex, Aging and Antiretroviral Pharmacokinetics

HIV Infections

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Palo Alto Medical...

Completed

Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2

Prostate Cancer

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Palo Alto Medical...

Completed

Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1

Healthy Men Age 50 Who Are Considering PSA Screening

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

ARV Concentrations in Hair

HIV

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Terminated

MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection

HIV Infections

United States
Cynthia L Gay, MD
National Institute of Allergy and Infectious Diseases (NIAID); Argos Therapeutics

Completed

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

HIV

United States
The University of Texas Health Science Center at...
National Institute of Allergy and Infectious Diseases (NIAID); Regeneron Pharmaceuticals

Recruiting

Dupilumab Effects Against Aeroallergen Challenge

Asthma, Allergic

United States
University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Takeda...

Recruiting

Pathophysiology of Uric Acid Nephrolithiasis (IUAN)

Uric Acid Kidney Stone Disease

United States
NYU Langone Health
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings (iCPR2)

Pneumonia | Strep Throat

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART

HIV-1 Infection

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Recruiting

COVID-19 Vaccine Responses in PIDD Subjects

Common Variable Immunodeficiency | X-linked Agammaglobulinemia | Primary Immune Deficiency | Primary Antibody Deficiencies | CVID | XLA | Secondary Hypogammaglobulinemia

United States

Clinical Trials Sponsored by North Texas Infectious Disease Consultants

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations